| Trial Identifier: | D4194R00004 |
| Sponsor: | AstraZeneca |
| Start Date: | January 2020 |
| Primary Completion Date: | December 2024 |
| Study Completion Date: | December 2024 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| South Korea, South Korea | Bucheon-si, South Korea, South Korea |
| South Korea, South Korea | Busan, South Korea, South Korea |
| South Korea, South Korea | Changwon, South Korea, South Korea |
| South Korea, South Korea | Changwon-si, South Korea, South Korea |
| South Korea, South Korea | Cheonan, South Korea, South Korea |
| South Korea, South Korea | Chuncheon-si, South Korea, South Korea |
| South Korea, South Korea | Goyang-si, South Korea, South Korea |
| South Korea, South Korea | Gwangju, South Korea, South Korea |
| South Korea, South Korea | Iksan-si, South Korea, South Korea |
| South Korea, South Korea | Incheon, South Korea, South Korea |
| South Korea, South Korea | Jeju-do, South Korea, South Korea |
| South Korea, South Korea | Jeonju-si, South Korea, South Korea |
| South Korea, South Korea | Pohang-si, South Korea, South Korea |
| South Korea, South Korea | Seongnam-Si, South Korea, South Korea |
| South Korea, South Korea | Uijeongbu-si, South Korea, South Korea |
| South Korea, South Korea | Wonju-si, South Korea, South Korea |
| South Korea, South Korea | Yangsan-si, South Korea, South Korea |